Systematic analysis demonstrates UCP1 presence in non-adipose tissues during embryogenesis, suggesting roles beyond thermogenesis.
UCP1, a mitochondrial protein traditionally regarded as exclusive to thermogenic adipocytes, and Ucp1-promoter-driven Cre is widely used in gene manipulation in thermogenic adipocytes. However, new evidence suggests that Ucp1-promoter-driven Cre is also active in non-adipocyte types. The presence and role of UCP1 in non-adipose tissues during development, and its potential non-thermogenic functions, remain under debate. This study systematically investigated UCP1 expression patterns from embryogenesis to adulthood using Ucp1 GFP/+ (knock-in), Ucp1 CreERT2/+ (knock-in) and Ucp1 Cre/+ (transgenic) mice crossed with Ai9-tdTomato-Red mice, complemented by single-cell RNA sequencing and immunostaining analyses. Ucp1 CreERT2/CreERT2 knockout mice were utilized to evaluate developmental consequences of UCP1 deficiency. Significantly, UCP1 expression initiated in non-thermogenic tissues by embryonic day 10.5, before adipose tissue formation, notably in the brain, eye, ear, mammary gland, kidney, and reproductive systems. UCP1 was more broadly expressed in non-adipose tissues during embryonic stages compared to adulthood, particularly in the epithelial cells of these non-adipose tissues. UCP1 knockout mice exhibited retinal developmental defects, suggesting physiological roles for UCP1 beyond thermogenesis in non-adipose tissues. This study highlights that using Ucp1-promoter-driven tamoxifen-inducible Cre can minimize off-target effects in gene manipulation of thermogenic adipocytes compared to the traditional transgenic Cre strategy.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: